Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...

North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for ...

Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...

Lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for more North Dakotans.

High Return on Equity: With a three-year average ROE of 101% and an ROE of 123% in the last year, the company has ...

IU Health Metro Region President Dr. Ryan Nagy, who joined IU Health 13 years ago, was also interim president of Riley ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

Indian pharmaceutical company Remedium Lifecare Limited, listed on the BSE Code 539561, has recently made a significant ...

This top healthcare company trades at 13 times forward earnings. It has a diverse portfolio of products, yields 3.6% at the ...

You deposit a lump sum or contribute monthly and acquire your very own slice of the world's starriest companies.